Trademark: 78357607
Word
TARGETED MEDICINES BY DESIGN
Status
Dead
Status Code
602
Status Date
Tuesday, April 25, 2006
Serial Number
78357607
Mark Type
3000
Filing Date
Monday, January 26, 2004
Abandoned Date
Tuesday, March 28, 2006

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives
42 Pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, namely conducting clinical trials of pharmaceuticals

Trademark Events
Apr 25, 2006
Abandonment Notice Mailed - Failure To Respond
Apr 25, 2006
Abandonment - Failure To Respond Or Late Response
Sep 27, 2005
Inquiry As To Suspension Mailed
Sep 27, 2005
Suspension Inquiry Written
Sep 24, 2005
Lie Checked Susp - To Atty For Action
Mar 14, 2005
Letter Of Suspension Mailed
Mar 13, 2005
Suspension Letter Written
Mar 11, 2005
Amendment From Applicant Entered
Feb 25, 2005
Correspondence Received In Law Office
Feb 25, 2005
Paper Received
Aug 19, 2004
Non-Final Action Mailed
Aug 18, 2004
Assigned To Examiner
Feb 4, 2004
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24